Five hundred people in the Canadian province of New Brunswick were diagnosed with a "mystery brain disorder" that resembled ...

Researchers at Rutgers Robert Wood Johnson Medical School in New Brunswick are enrolling participants in the National ...

A new international study led by researchers from UNSW Sydney's Center for Healthy Brain Aging (CHeBA) has developed the ...

Roughly 25 percent of dementia patients were prescribed at least one ‘potentially inappropriate’ drug between 2013 and 2021 ...

Despite years of clinical guidelines warning against the practice, one in four Medicare beneficiaries with dementia is ...

Funds to support ongoing Phase 1 trial of MNA-001 and validation of translational biomarkers for TREM2 function in Alzheimer's Work will inform Phase 2 trials assessing the potential of MNA-001 to ...

Despite years of clinical guidelines warning against the practice, one in four Medicare beneficiaries with dementia is ...

AI prioritizes clinical trials by identifying unmet medical needs, optimizing resource allocation, and focusing on conditions ...

A new drug candidate shows promise by reversing cognitive decline in advanced Alzheimer's disease by restoring brain balance ...

There is no strong evidence that replenishing hormones after menopause is linked to dementia, according to a sweeping ...

The authors of the study, published in Cell Reports Medicine, are optimistic that it could pave the way for potential ...

Scientists behind the study say that if the harmful influence of the gene could be neutralised, up to three-quarters - and ...